Olema Pharmaceuticals, Inc.(OLMA)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OLMA Olema Pharmaceuticals, Inc.

休市中 11-22 16:00:00 EST

8.78

+0.91

+11.56%

盘后8.78

+0.000.00%

19:26 EST

最高8.90	最低7.91	成交量120.62万
今开8.21	昨收7.87	日振幅12.58%
总市值5.03亿	流通市值2.53亿	总股本5,726万
成交额1,038万	换手率4.19%	流通股本2,882万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"OLMA","market":"US","secType":"STK","nameCN":"Olema Pharmaceuticals, Inc.","latestPrice":8.78,"timestamp":1732309200000,"preClose":7.87,"halted":0,"volume":1206240,"hourTrading":{"tag":"盘后","latestPrice":8.78,"preClose":8.78,"latestTime":"19:26 EST","volume":14696,"amount":129031.54,"timestamp":1732321613446},"delay":0,"floatShares":28817530,"shares":57257493,"eps":-2.286966,"marketStatus":"休市中","marketStatusCode":7,"change":0.91,"latestTime":"11-22 16:00:00 EST","open":8.21,"high":8.9,"low":7.91,"amount":10377094.546559999,"amplitude":0.125794,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.286966,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1605762000000,"adjPreClose":7.87,"preHourTrading":{"tag":"盘前","latestPrice":7.87,"preClose":7.87,"latestTime":"09:12 EST","volume":1,"amount":7.87,"timestamp":1732284734954},"postHourTrading":{"tag":"盘后","latestPrice":8.78,"preClose":8.78,"latestTime":"19:26 EST","volume":14696,"amount":129031.54,"timestamp":1732321613446},"volumeRatio":1.755581,"impliedVol":0.3314,"impliedVolPercentile":0.0476},"requestUrl":"/m/hq/s/OLMA/wiki","defaultTab":"wiki","newsList":[{"id":"2484715456","title":"美国研究综述-Apellis Pharmaceuticals、Energizer Holdings、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2484715456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484715456?lang=zh_cn&edition=full","pubTime":"2024-11-20 14:56","pubTimestamp":1732085774,"startTime":"0","endTime":"0","summary":"    路透11月20日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Apellis Pharmaceuticals、Energizer Holdings 和沃尔玛。要闻              * Apellis Pharmaceuticals Inc   ：摩根大通将目标价从57美元下调至50美元             * Chord Energy Corp   ：加拿大皇家银行将目标价从185美元下调至180美元             * Energizer Holdings Inc   ：摩根大通将其评级从 \"减持 \"上调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNPR","BK4187","LU1267930490.SGD","LU2286300806.USD","IIIV","LU2756315318.SGD","BK4596","DYN","AZEK","LU0528227936.USD","OCSL","PIII","BK4579","NOG","SWTX","ANNX","LU1988902786.USD","VVV","IE00BZ1G4Q59.USD","NUVL","LOW","VIR","LU1066053197.SGD","IE00B19Z8X17.USD","LU2430703251.USD","TVTX","LH","LU1951198990.SGD","ENR","CASY","VERA","BRBR","LU0265550946.USD","AVAV","ABUS","LU0310799852.SGD","BK4086","APLS","CHRD","LU1551013425.SGD","LU0006061336.USD","OLMA","BBIO","BK4505","BK4528","FSUN","PBF","WMT","CRM","BERY"],"gpt_icon":0},{"id":"2484674973","title":"Olema Pharmaceuticals, Inc.盘中异动 股价大跌5.13%报8.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484674973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484674973?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:26","pubTimestamp":1731943574,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时26分，Olema Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.13%。截至发稿，该股报8.70美元/股，成交量5.469万股，换手率0.10%，振幅6.38%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118232615abccc633&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118232615abccc633&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","OLMA","BK4139"],"gpt_icon":0},{"id":"2483389160","title":"Olema Pharmaceuticals, Inc.盘中异动 股价大跌5.40%报10.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483389160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483389160?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:27","pubTimestamp":1731601659,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日00时27分，Olema Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.40%。截至发稿，该股报10.86美元/股，成交量11.184万股，换手率0.20%，振幅6.93%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、奥麦罗制药涨幅较大，Elevai Labs, Inc.、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为2991.44%、334.48%、43.79%，振幅较大的相关个股有Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Abpro Holdings, Inc，振幅分别为112.92%、86.36%、79.03%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115002740971a69b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115002740971a69b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OLMA","BK4505","BK4139"],"gpt_icon":0},{"id":"2483043864","title":"Olema Pharmaceuticals, Inc.2024财年第三财季实现净利润-34.56百万美元，同比减少60.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483043864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483043864?lang=zh_cn&edition=full","pubTime":"2024-11-14 08:00","pubTimestamp":1731542426,"startTime":"0","endTime":"0","summary":"11月14日，Olema Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-34.56百万美元，同比减少60.74%；其中营业收入为0.00美元，每股基本收益为-0.60美元。从资产负债表来看，Olema Pharmaceuticals, Inc.总负债31.26百万美元，其中短期债务1.14百万美元，资产负债比为0.08，流动比率为0.08。机构评级：截至2024年11月14日，当前有7家机构对Olema Pharmaceuticals, Inc.目标价做出预测，其中目标均价为28.14美元，其中最低目标价为20.00美元，最高目标价为31.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080031abbee556&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080031abbee556&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OLMA"],"gpt_icon":0},{"id":"2483881764","title":"Olema Pharmaceuticals, Inc.盘中异动 急速拉升5.37%报12.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483881764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483881764?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:31","pubTimestamp":1731508263,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时31分，Olema Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.37%。截至发稿，该股报12.16美元/股，成交量4969股，换手率0.01%，振幅1.04%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Kairos Pharma, Ltd.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为325.16%、168.31%、84.06%，振幅较大的相关个股有Entero Therapeutics Inc.、Kairos Pharma, Ltd.、Turnstone Biologics Corp.，振幅分别为8.29%、7.79%、7.65%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223103971a645f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223103971a645f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","OLMA"],"gpt_icon":0},{"id":"2481360057","title":"Olema Pharmaceuticals Inc 预计每股亏损58美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481360057","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481360057?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:21","pubTimestamp":1730902888,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals Inc 预计每股亏损58美分 - 财报前瞻Olema Pharmaceuticals Inc OLMA.OQ OLMA.O预计在11月8日公布截至2024年9月30日的业绩时，季度收入将不会有任何变化(预计)。LSEG的分析师平均预计Olema Pharmaceuticals Inc每股亏损58美分。华尔街对 Olema Pharmaceuticals Inc 的 12 个月目标价中位数为 29.50 美元，高于其最新收盘价 12.06 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4S3MD2HW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OLMA"],"gpt_icon":0},{"id":"2475391426","title":"Olema Pharmaceuticals, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475391426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475391426?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:10","pubTimestamp":1729091439,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时10分，Olema Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.02%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，180 Life Sciences Corp.、Korro Bio, Inc.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为5880.17%、1061.88%、420.50%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.，振幅分别为623.68%、279.52%、126.58%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016231039971a0a8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016231039971a0a8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","OLMA","BK4139"],"gpt_icon":0},{"id":"2474152600","title":"Olema Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474152600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474152600?lang=zh_cn&edition=full","pubTime":"2024-10-11 23:24","pubTimestamp":1728660246,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日23时24分，Olema Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.42%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Conduit Pharmaceuticals Inc.、Aditxt, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为255.09%、187.02%、26.70%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为170.59%、95.70%、70.00%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112324069719fb51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112324069719fb51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","OLMA","BK4139"],"gpt_icon":0},{"id":"2459145479","title":"Olema Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.03%报12.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459145479","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459145479?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:45","pubTimestamp":1723733133,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时45分，Olema Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.03%。截至发稿，该股报12.63美元/股，成交量4.2093万股，换手率0.07%，振幅3.54%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Cingulate Inc.、Tempest Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为6065.96%、2010.73%、534.82%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Tempest Therapeutics, Inc.、Cingulate Inc.，振幅分别为103.98%、79.83%、70.46%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522453398e350d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081522453398e350d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OLMA","BK4505","BK4139"],"gpt_icon":0},{"id":"2459400483","title":"Olema Pharmaceuticals, Inc.盘中异动 急速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459400483","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459400483?lang=zh_cn&edition=full","pubTime":"2024-08-15 01:43","pubTimestamp":1723657423,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日01时43分，Olema Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.11%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Unicycive Therapeutics, Inc.、Notable Labs, Ltd.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Tc Biopharm  Plc较为活跃，换手率分别为93.42%、80.48%、70.22%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm  Plc，振幅分别为60.83%、58.52%、49.86%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。OP-3136是该公司产品管线中的另一款候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081501434398e34f5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081501434398e34f5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","OLMA"],"gpt_icon":0},{"id":"1114808506","title":"异动解读 | Olema Pharmaceuticals盘中大涨5.74% 机构看好公司前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1114808506","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114808506?lang=zh_cn&edition=full","pubTime":"2024-08-14 00:52","pubTimestamp":1723567958,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals, Inc.今日盘中大涨5.74%,引发市场关注。分析人士认为,这可能与机构对该公司前景的看好有关。根据最新财报数据,Olema Pharmaceuticals去年虽然没有实现营收,但也未产生较大亏损,净利润为-3038万美元。而在9家参与评级的机构中,100%的机构给予该股买入评级,看好公司未来发展前景。作为一家临床阶段的生物制药公司,Olema Pharmaceuticals专注于下一代女性癌症靶向疗法的研发。其产品管线中的OP-1250和OP-3136等候选药物有望为女性癌症患者带来更好的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OLMA"],"gpt_icon":0},{"id":"2459318164","title":"Olema Pharmaceuticals, Inc.盘中异动 快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459318164","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459318164?lang=zh_cn&edition=full","pubTime":"2024-08-14 00:31","pubTimestamp":1723566684,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日00时31分，Olema Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.00%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.11%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Orgenesis Inc.涨幅较大，Genprex, Inc.、冠科美博、Oragenics Inc.较为活跃，换手率分别为136.13%、131.85%、34.96%，振幅较大的相关个股有冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029、Tempest Therapeutics, Inc.，振幅分别为78.40%、40.95%、39.71%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814003124ab5d9ca7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814003124ab5d9ca7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OLMA","BK4505"],"gpt_icon":0},{"id":"2458697379","title":"Olema Pharmaceuticals, Inc.2024财年第二财季实现净利润-30.38百万美元，同比减少51.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458697379","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458697379?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:10","pubTimestamp":1723392648,"startTime":"0","endTime":"0","summary":"8月12日，Olema Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-30.38百万美元，同比减少51.14%；其中营业收入为0.00美元，每股基本收益为-0.54美元。从资产负债表来看，Olema Pharmaceuticals, Inc.总负债27.39百万美元，其中短期债务1.10百万美元，资产负债比为0.10，流动比率为0.10。机构评级：截至2024年8月12日，当前有8家机构对Olema Pharmaceuticals, Inc.目标价做出预测，其中目标均价为27.88美元，其中最低目标价为20.00美元，最高目标价为31.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200105495904281&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200105495904281&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OLMA"],"gpt_icon":0},{"id":"2457821489","title":"Olema Pharmaceuticals, Inc.盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457821489","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457821489?lang=zh_cn&edition=full","pubTime":"2024-08-08 00:28","pubTimestamp":1723048139,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日00时28分，Olema Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.31%。截至发稿，该股报13.20美元/股，成交量24.8006万股，换手率0.43%，振幅8.15%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.11%。其相关个股中，G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为4858.32%、1583.37%、326.10%，振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.，振幅分别为101.30%、69.66%、55.91%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808002859941ff15a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808002859941ff15a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","OLMA"],"gpt_icon":0},{"id":"2456890042","title":"Olema Pharmaceuticals, Inc.盘中异动 股价大跌13.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456890042","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456890042?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:33","pubTimestamp":1722605623,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时33分，Olema Pharmaceuticals, Inc.股票出现异动，股价大幅跳水13.97%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Exicure, Inc.、Os Therapies Incorporated、Dermata Therapeutics, Inc.涨幅较大，Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为330.21%、92.40%、20.52%，振幅较大的相关个股有Exicure, Inc.、Anew Medical Inc C/Wts 21/06/2029 、Dermata Therapeutics, Inc.，振幅分别为33.34%、17.87%、16.46%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。OP-3136是该公司产品管线中的另一款候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221334495780d66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221334495780d66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OLMA","BK4505"],"gpt_icon":0},{"id":"2456440647","title":"Olema Pharmaceuticals Inc   预计每股亏损 55 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456440647","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456440647?lang=zh_cn&edition=full","pubTime":"2024-08-02 19:06","pubTimestamp":1722596772,"startTime":"0","endTime":"0","summary":"   * Olema Pharmaceuticals Inc    将于8月6日公布截至2024年6月30日的财报() 预计该公司的季度收入将保持不变。*    * LSEG的分析师平均预计Olema Pharmaceuticals Inc每股亏损55美分。* 华尔街对 Olema Pharmaceuticals Inc 的 12 个月目标价中位数为 29.00 美元，高于其上次收盘价 16.46 美元。8月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Olema Pharmaceuticals Inc   预计每股亏损 55 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OLMA"],"gpt_icon":0},{"id":"2456161975","title":"Olema Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.05%报16.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456161975","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456161975?lang=zh_cn&edition=full","pubTime":"2024-08-01 03:06","pubTimestamp":1722452817,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日03时06分，Olema Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.05%。截至发稿，该股报16.43美元/股，成交量27.6685万股，换手率0.49%，振幅6.97%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。其相关个股中，Molecular Partners Ag、Alpha Tau Medical Ltd C/Wts 、木薯科学涨幅较大，Cns Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为753.39%、171.39%、159.99%，振幅较大的相关个股有Molecular Partners Ag、Renovaro Inc.、Alpha Tau Medical Ltd C/Wts ，振幅分别为89.73%、79.10%、52.94%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801030657af952978&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801030657af952978&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OLMA","BK4505","BK4139"],"gpt_icon":0},{"id":"2454517340","title":"Olema Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.29%报15.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454517340","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454517340?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:38","pubTimestamp":1722001122,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时38分，Olema Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.29%。截至发稿，该股报15.47美元/股，成交量1.1634万股，换手率0.02%，振幅3.68%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Windtree Therapeutics, Inc.、Nutriband Inc C/Wts 、Cel-Sci Corporation涨幅较大，Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Cel-Sci Corporation较为活跃，换手率分别为3311.89%、103.04%、38.74%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Cel-Sci Corporation、Promis Neurosciences Inc.，振幅分别为45.29%、39.67%、20.82%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213842941fb1e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213842941fb1e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","OLMA"],"gpt_icon":0},{"id":"2453712384","title":"Olema Pharmaceuticals, Inc.盘中异动 急速拉升5.17%报15.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453712384","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453712384?lang=zh_cn&edition=full","pubTime":"2024-07-23 03:16","pubTimestamp":1721675778,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日03时16分，Olema Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.17%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为123.64%、116.46%、84.73%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、Mei Pharma, Inc.、木薯科学，振幅分别为44.07%、37.06%、33.41%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230316199681ef21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230316199681ef21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OLMA","BK4505"],"gpt_icon":0},{"id":"2451186915","title":"Olema Pharmaceuticals, Inc.盘中异动 股价大涨5.10%报13.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451186915","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451186915?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:02","pubTimestamp":1721138549,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日22时02分，Olema Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.10%。截至发稿，该股报13.81美元/股，成交量3.2225万股，换手率0.06%，振幅3.20%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1784.70%、1021.19%、95.62%，振幅较大的相关个股有Scisparc Ltd.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为40.48%、40.19%、39.04%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162202309681d344&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162202309681d344&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OLMA","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.olema.com","stockEarnings":[{"period":"1week","weight":-0.0425},{"period":"1month","weight":-0.2628},{"period":"3month","weight":-0.2653},{"period":"6month","weight":-0.0309},{"period":"1year","weight":-0.3615},{"period":"ytd","weight":-0.3742}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Olema Pharmaceuticals, Inc.位于加利福尼亚州的旧金山，于2006年8月7日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，致力于发现，开发和商业化针对女性癌症的下一代靶向疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":0.117684},{"month":2,"riseRate":0,"avgChangeRate":-0.132995},{"month":3,"riseRate":0,"avgChangeRate":-0.124834},{"month":4,"riseRate":0.25,"avgChangeRate":-0.069302},{"month":5,"riseRate":0.5,"avgChangeRate":0.037378},{"month":6,"riseRate":1,"avgChangeRate":0.322044},{"month":7,"riseRate":0.5,"avgChangeRate":0.131009},{"month":8,"riseRate":0.5,"avgChangeRate":-0.008816},{"month":9,"riseRate":0.5,"avgChangeRate":-0.037882},{"month":10,"riseRate":0.5,"avgChangeRate":0.095944},{"month":11,"riseRate":0.25,"avgChangeRate":-0.275369},{"month":12,"riseRate":0.5,"avgChangeRate":-0.032037}],"exchange":"NASDAQ","name":"Olema Pharmaceuticals, Inc.","nameEN":"Olema Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Olema Pharmaceuticals, Inc.(OLMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Olema Pharmaceuticals, Inc.(OLMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Olema Pharmaceuticals, Inc.,OLMA,Olema Pharmaceuticals, Inc.股票,Olema Pharmaceuticals, Inc.股票老虎,Olema Pharmaceuticals, Inc.股票老虎国际,Olema Pharmaceuticals, Inc.行情,Olema Pharmaceuticals, Inc.股票行情,Olema Pharmaceuticals, Inc.股价,Olema Pharmaceuticals, Inc.股市,Olema Pharmaceuticals, Inc.股票价格,Olema Pharmaceuticals, Inc.股票交易,Olema Pharmaceuticals, Inc.股票购买,Olema Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Olema Pharmaceuticals, Inc.(OLMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Olema Pharmaceuticals, Inc.(OLMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况